| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 02/27/2003 | US20030040007 Human BMP-7 promoter and method for exploring bone-related substance by using the same |
| 02/27/2003 | US20030040006 Methods and kits for obtaining DNA end sequence information for large cloned inserts and uses thereof |
| 02/27/2003 | US20030040005 Detection of prostate cancer in humans; obtain tissue sample, extract nucleotide sequences, incubate with probe, detect signal from probe, presence of signal indicates cancer |
| 02/27/2003 | US20030040004 Coplanar waveguide biosensor for detecting molecular or cellular events |
| 02/27/2003 | US20030040003 Detection of mutation in preferential nucleotide sequences; obtain cells, fuse, recover hybrids, monitor gene activity in hybrids, detect aberrant gene activity |
| 02/27/2003 | US20030040000 Methods for attaching nucleic acid molecules to electrically conductive surfaces |
| 02/27/2003 | US20030039999 B7 related protein-2 molecules and uses thereof |
| 02/27/2003 | US20030039998 Evaluating tumor propagation in humans; obtain tissue sample, monitor cyclin dependent kinase expression and activity, compare to control, amplified kinase activity and expression indicates cancer |
| 02/27/2003 | US20030039997 Pentopyranosyl nucleic acid arrays, and uses thereof |
| 02/27/2003 | US20030039996 Detecting preferential genetic marker in genome sample; obtain nucleotide sequence sample, incubate with primers, amplify, recover reaction product, incubate with probe, detect signal from sample |
| 02/27/2003 | US20030039994 Nucleotide sequences coding polypeptide for use in the treatment diagnosis and prevention of cancer |
| 02/27/2003 | US20030039993 Nucleotide sequences coding polypeptide for use in the treatment diagnosis and prevention of cancer |
| 02/27/2003 | US20030039992 Mixture for use in the amplification of nucleotide sequences |
| 02/27/2003 | US20030039990 Expression vector for use as gene transfer tool ingenetic engineering |
| 02/27/2003 | US20030039989 Method for constructing an expression library and uses thereof |
| 02/27/2003 | US20030039988 Nucleotide sequences for use as tools in genetic engineering |
| 02/27/2003 | US20030039987 Defects in periaxin associated with myelinopathies |
| 02/27/2003 | US20030039986 Compositions and methods relating to prostate specific genes and proteins |
| 02/27/2003 | US20030039985 Modified polynucleotides and uses thereof |
| 02/27/2003 | US20030039983 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cancer |
| 02/27/2003 | US20030039982 Nucleotide sequences coding polypeptide for use in the diagnosis treatment and prevention of tumors |
| 02/27/2003 | US20030039981 Probes for use as diagnostic tools in the detection of parasites |
| 02/27/2003 | US20030039980 Evaluating receptor protein response to modulator; obtain protein sample, incubate with modulator, monitor binding activity and complex formation, adjustment binding activity and complex formation indicates modulators |
| 02/27/2003 | US20030039979 Detection of genetic disorder in humans; obtain tissue sample, determine genotype, evaluate for genetic disorder |
| 02/27/2003 | US20030039978 Electron induced fluorescent method for nucleic acid sequencing |
| 02/27/2003 | US20030039977 Carbamate-derivatized nucleosides and oligonucleosides |
| 02/27/2003 | US20030039976 Methods for base counting |
| 02/27/2003 | US20030039975 Detection gene expression; measurement mutant genomes; laser radiation |
| 02/27/2003 | US20030039974 One step sample preparation and detection of nucleic acids in complex biological samples |
| 02/27/2003 | US20030039973 Human single nucleotide polymorphisms |
| 02/27/2003 | US20030039972 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/27/2003 | US20030039971 Nucleotide sequences coding polypeptides for use in the diagnosis, treatment and prevention of cancer, skin, vascular, kidney and inflammatory disorders |
| 02/27/2003 | US20030039970 Diagnosing cancer in humans; obtain tissue sample, determine concentration of calreticulin in sample, compare to control, evaluate for cancer |
| 02/27/2003 | US20030039969 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/27/2003 | US20030039967 High throughput assay system using mass spectrometry |
| 02/27/2003 | US20030039966 Genetic engineering; bone disorders |
| 02/27/2003 | US20030039965 Algorithmic determination of flanking DNA sequences that control the expression of sets of genes in prokaryotic, archea and eukaryotic genomes |
| 02/27/2003 | US20030039964 Method |
| 02/27/2003 | US20030039961 Nucleic acid sequence detection employing amplification probes |
| 02/27/2003 | US20030039959 Detection of premature tumor cells in mammary gland tissue; obtain mammary gland tissue, incubate with diagnostic agent, monitor sample for binding and signal, presence of signal indicates premature cancer |
| 02/27/2003 | US20030039958 Screening polypeptides pool to detect preferential polypeptide activity; immobilize target nucleotide sequences on microarray, express nucleotide sequences, recover protein, interact with preferential polypeptide, monitor activity |
| 02/27/2003 | US20030039957 Functional protein expression for rapid cell-free phenotyping |
| 02/27/2003 | US20030039954 Viral nucleotide sequences for use in the diagnosis, prevention and treatment of viral diseases |
| 02/27/2003 | US20030039664 Isolated nucleotide sequences associated with multiple sclerosis or rheumatoid arthritis and a process of detecting |
| 02/27/2003 | US20030039663 Vaccine; neutralizing antibodies; detecting infections |
| 02/27/2003 | US20030039648 Compositions and methods for the diagnosis and treatment of tumor |
| 02/27/2003 | US20030039646 Receptor interacting protein, which binds to itself and to other intracellular modulatory proteins; treating tumor cells or HIV-infected cells |
| 02/27/2003 | US20030038828 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/27/2003 | US20030038827 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/27/2003 | US20030038826 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/27/2003 | US20030038071 System and method for manipulating magnetically responsive particles in fluid samples to collect DNA or RNA from a sample |
| 02/27/2003 | CA2497343A1 Systems and methods for screening pharmaceutical chemicals |
| 02/27/2003 | CA2459450A1 Yeast arrays, methods of making such arrays, and methods of analyzing such arrays |
| 02/27/2003 | CA2458890A1 Recombinant anti-plasmodium falciparum antibodies |
| 02/27/2003 | CA2458648A1 Secreted proteins |
| 02/27/2003 | CA2458643A1 Nucleic-acid associated proteins |
| 02/27/2003 | CA2458625A1 Transporters and ion channels |
| 02/27/2003 | CA2458127A1 Nucleic acid amplification methods |
| 02/27/2003 | CA2457932A1 Sodium channel regulators and modulators |
| 02/27/2003 | CA2457823A1 Methods for diagnosing and treating neoplasias using nf-at transcription factors |
| 02/27/2003 | CA2457819A1 Nucleic acid and amino acid sequences involved in pain |
| 02/27/2003 | CA2457799A1 Method and quantification assay for determining c-kit/scf/pakt status |
| 02/27/2003 | CA2457789A1 Conformation-activity relationship of apoptosis-inducing phosphodiester oligonucleotides |
| 02/27/2003 | CA2457787A1 Use of associations between at least one nucleic sequence polymorphism of the sh2 gene and at least one seed quality characteristic in plant selection methods |
| 02/27/2003 | CA2457783A1 Oligonucleotide compositions and their use to induce apoptosis |
| 02/27/2003 | CA2457730A1 Solid compositions for selective adsorption from complex mixtures |
| 02/27/2003 | CA2457632A1 Identification and isolation of somatic stem cells and uses thereof |
| 02/27/2003 | CA2457611A1 Novel molecular target for neurotoxicity |
| 02/27/2003 | CA2457579A1 Use of intrinsic reporters of cell signaling for high content drug profiling and toxicity screening |
| 02/27/2003 | CA2457432A1 Method and system for profiling biological systems |
| 02/27/2003 | CA2457427A1 Compositions and methods comprising control nucleic acid |
| 02/27/2003 | CA2457405A1 Compositions and methods relating to benzodiazepine compounds |
| 02/27/2003 | CA2457370A1 Age-associated markers |
| 02/27/2003 | CA2457365A1 Polymorphisms associated with ion-channel disease |
| 02/27/2003 | CA2457321A1 Combinatorial methods for inducing cancer cell death |
| 02/27/2003 | CA2457226A1 Nucleic acids and proteins of insect or83b odorant receptor genes and uses thereof |
| 02/27/2003 | CA2457095A1 Zinc finger domain libraries |
| 02/27/2003 | CA2457066A1 Human protooncogene kg-20 and protein encoded therein |
| 02/27/2003 | CA2457043A1 Medicinal use of histone deacetylase inhibitor and method of evaluating antitumor effect thereof |
| 02/27/2003 | CA2456340A1 Propagation of human hepatoblastoma cell in non-human animals |
| 02/27/2003 | CA2456334A1 Molecular characteristics of non-small cell lung cancer |
| 02/27/2003 | CA2454879A1 Retrovirus isolated from mantle histiocytes in mantle cell lymphoma |
| 02/27/2003 | CA2454756A1 Methods and compounds for the targeting of protein to exosomes |
| 02/27/2003 | CA2450215A1 Method of labelling crnas for probing oligo-based microarrays |
| 02/27/2003 | CA2443532A1 Measurement of microbiological activity in an opaque medium |
| 02/27/2003 | CA2426171A1 Method and probes for the genetic diagnosis of hereditary haemochromatosis |
| 02/26/2003 | WO2002018407A2 Antisense oligonucleotides against vanilloid receptor 1 |
| 02/26/2003 | EP1286165A2 Neuropeptide receptor and uses thereof |
| 02/26/2003 | EP1286164A2 Methods and apparatus for improved luminescence assays |
| 02/26/2003 | EP1285971A2 Methods for the phenotypic and genotypic assessment of the drug sensitivity of HIV integrase variants |
| 02/26/2003 | EP1285970A2 Metastasis-associated genes |
| 02/26/2003 | EP1285967A2 Human retroviral packaging cell line |
| 02/26/2003 | EP1285964A2 Human Mater proteins |
| 02/26/2003 | EP1285960A2 Virulence genes from Salmonella typhimurium |
| 02/26/2003 | EP1285390A2 Method and system for the assembly of a whole genome using a shot-gun data set |
| 02/26/2003 | EP1285290A1 Micro-array evanescent wave fluorescence detection device |
| 02/26/2003 | EP1285273A1 Il-6 detection for predicting risks of preterm delivery |
| 02/26/2003 | EP1285272A2 Compositions and methods for screening therapeutic agents |
| 02/26/2003 | EP1285270A2 Method for identifying compounds for modulating the activity of a tumour suppressor protein |
| 02/26/2003 | EP1285269A2 Lipid uptake assays |